Impact of tigecycline versus imipenem–cilastatin on fibrinogen levels following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a randomized-controlled study

References

• Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003 Oct 15;21(20):3737–43.10.1200/JCO.2003.04.187
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995 Jan;221(1):29–42.10.1097/00000658-199501000-00004
   PubMed Web of Science ®Google Scholar
• Arslan NC, Sokmen S, Avkan-Oguz V, Obuz F, Canda AE, Terzi C, et al. Infectious complications after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. Sur Infect. 2017 Feb/Mar;18(2):157–63.10.1089/sur.2016.102
   PubMed Web of Science ®Google Scholar
• Mizumoto A, Canbay E, Hirano M, Takao N, Matsuda T, Ichinose M, et al. Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a single institution in Japan. Gastroenterol Res Pract. 2012;2012:836425.
   PubMed Web of Science ®Google Scholar
• Canda AE, Sokmen S, Terzi C, Arslan C, Oztop I, Karabulut B, et al. Complications and toxicities after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2013 Apr;20(4):1082–7.10.1245/s10434-012-2853-x
   PubMed Web of Science ®Google Scholar
• Valle M, Federici O, Carboni F, Toma L, Gallo MT, Prignano G, et al. Postoperative infections after cytoreductive surgery and HIPEC for peritoneal carcinomatosis: proposal and results from a prospective protocol study of prevention, surveillance and treatment. Eur J Sur Oncol (EJSO). 2014 Aug;40(8):950–6.10.1016/j.ejso.2013.10.015
   PubMed Web of Science ®Google Scholar
• Petersen PJ, Jacobus NV, Weiss WJ, Sum PE, Testa RT. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob Agents Chemother. 1999 Apr;43(4):738–44.
   PubMed Web of Science ®Google Scholar
• Breedt J, Teras J, Gardovskis J, Maritz FJ, Vaasna T, Ross DP, et al. Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam. Antimicrob Agents Chemother. 2005 Nov;49(11):4658–66.10.1128/AAC.49.11.4658-4666.2005
   PubMed Web of Science ®Google Scholar
• Oliva ME, Rekha A, Yellin A, Pasternak J, Campos M, Rose GM, et al. A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744]. BMC Infect Dis. 2005 Oct;5(1):997.10.1186/1471-2334-5-88
   Google Scholar
• Kasbekar N. Tigecycline: a new glycylcycline antimicrobial agent. Am J Health Syst Pharm. 2006 Jul 01;63(13):1235–43.10.2146/ajhp050487
   PubMed Web of Science ®Google Scholar
• Korth-Bradley JM, McGovern PC, Salageanu J, Matschke K, Plotka A, Pawlak S. Tigecycline does not prolong corrected QT intervals in healthy subjects. Antimicrob Agents Chemother. 2013 Apr;57(4):1895–901.10.1128/AAC.01576-12
   PubMed Web of Science ®Google Scholar
• Rodvold KA, Gotfried MH, Cwik M, Korth-Bradley JM, Dukart G, Ellis-Grosse EJ. Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose. J Antimicrob Chemother. 2006 Dec;58(6):1221–9.10.1093/jac/dkl403
   PubMed Web of Science ®Google Scholar
• Stein GE, Smith CL, Missavage A, Saunders JP, Nicolau DP, Battjes SM, et al. Tigecycline penetration into skin and soft tissue. Surg Infect. 2011 Dec;12(6):465–7.10.1089/sur.2011.022
   PubMed Web of Science ®Google Scholar
• Secondo G, Vassallo F, Solari N, Moresco L, Percivale P, Zappi L, et al. Empirical first-line treatment with tigecycline for febrile episodes following abdominal surgery in cancer patients. Int J Antimicrob Agents. 2010 Nov;36(5):462–6.10.1016/j.ijantimicag.2010.07.019
   PubMed Web of Science ®Google Scholar
• Summary of Product Characteristics, European Medicines Agency 22 February 2016. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000644/WC500044508.pdf.
   Google Scholar
• Zhang Q, Zhou S, Zhou J. Tigecycline treatment causes a decrease in fibrinogen levels. Antimicrob Agents Chemother. 2015 Mar;59(3):1650–5.10.1128/AAC.04305-14
   PubMed Web of Science ®Google Scholar
• Routsi C, Kokkoris S, Douka E, Ekonomidou F, Karaiskos I, Giamarellou H. High-dose tigecycline-associated alterations in coagulation parameters in critically ill patients with severe infections. Int J Antimicrob Agents. 2015 Jan;45(1):90–3.10.1016/j.ijantimicag.2014.07.014
   PubMed Web of Science ®Google Scholar
• Yang L, Vuylsteke A, Gerrard C, Besser M, Baglin T. Postoperative fibrinogen level is associated with postoperative bleeding following cardiothoracic surgery and the effect of fibrinogen replacement therapy remains uncertain. J Thromb Haemost. 2013 Aug;11(8):1519–26.10.1111/jth.12304
   PubMed Web of Science ®Google Scholar
• Schulman S, Angeras U, Bergqvist D, Eriksson B, Lassen MR, Fisher W, et al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost. 2010 Jan;8(1):202–4.10.1111/jth.2009.8.issue-1
   PubMed Web of Science ®Google Scholar
• Besser MW, MacDonald SG. Acquired hypofibrinogenemia: current perspectives. J Blood Med. 2016;7:217–25.10.2147/JBM
   PubMed Web of Science ®Google Scholar
• Cooksley TJ, Haji-Michael P. Post-operative critical care management of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC). World J Surg Oncol. 2011 Dec;9(1):169.10.1186/1477-7819-9-169
   PubMedGoogle Scholar
• Korakianitis O, Daskalou T, Alevizos L, Stamou K, Mavroudis C, Iatrou C, et al. Lack of significant intraoperative coagulopathy in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) indicates that epidural anaesthesia is a safe option. Int J Hyperthermia. 2015;31(8):857–62.10.3109/02656736.2015.1075606
   PubMed Web of Science ®Google Scholar
• Hawkey CJ, Stirling Y, Chakrabarti R, Brozovic M, Cox AG, Meade TW. Haemostatic changes following surgery. Thromb Res. 1983 Oct 15;32(2):223–7.10.1016/0049-3848(83)90033-6
   PubMed Web of Science ®Google Scholar
• Naik BI, Pajewski TN, Bogdonoff DI, Zuo Z, Clark P, Terkawi AS, et al. Rotational thromboelastometry-guided blood product management in major spine surgery. J Neurosurg Spine. 2015 Aug;23(2):239–49.10.3171/2014.12.SPINE14620
   PubMed Web of Science ®Google Scholar
• Perisanidis C, Psyrri A, Cohen EE, Engelmann J, Heinze G, Perisanidis B, et al. Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: a systematic review and meta-analysis. Cancer Treat Rev. 2015 Dec;41(10):960–70.10.1016/j.ctrv.2015.10.002
   PubMed Web of Science ®Google Scholar
• Rossitto G, Piano S, Rosi S, Simioni P, Angeli P. Life-threatening coagulopathy and hypofibrinogenaemia induced by tigecycline in a patient with advanced liver cirrhosis. Eur J Gastroenterol Hepatol. 2014 Jun;26(6):681–4.
   PubMed Web of Science ®Google Scholar
• Sabanis N, Paschou E, Gavriilaki E, Kalaitzoglou A, Vasileiou S. Hypofibrinogenemia induced by tigecycline: a potentially life-threatening coagulation disorder. Infect Dis. 2015;47(10):743–6.10.3109/23744235.2015.1043942
   PubMed Web of Science ®Google Scholar
• Pieringer H, Schmekal B, Biesenbach G, Pohanka E. Severe coagulation disorder with hypofibrinogenemia associated with the use of tigecycline. Ann Hematol. 2010 Oct;89(10):1063–4.10.1007/s00277-010-0911-7
   PubMed Web of Science ®Google Scholar
• Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, et al. Diagnosis and management of complicated intra‐abdominal infection in adults and children: guidelines by the surgical infection society and the infectious diseases society of America. Clin Infect Dis. 2010 Jan 15;50(2):133–64.10.1086/648977
   PubMed Web of Science ®Google Scholar
• Mazuski JE, Tessier JM, May AK, Sawyer RG, Nadler EP, Rosengart MR, et al. The surgical infection society revised guidelines on the management of intra-abdominal infection. Sur Infect. 2017 Jan;18(1):1–76.10.1089/sur.2016.261
   PubMed Web of Science ®Google Scholar
• Kopp CW, Kopp HP, Steiner S, Kriwanek S, Krzyzanowska K, Bartok A, et al. Weight loss reduces tissue factor in morbidly obese patients. Obes Res. 2003 Aug;11(8):950–6.10.1038/oby.2003.131
   PubMedGoogle Scholar
• Conly J, Stein K. Reduction of vitamin K2 concentrations in human liver associated with the use of broad spectrum antimicrobials. Clin Invest Med. 1994 Dec;17(6):531–9.
   PubMed Web of Science ®Google Scholar
• Tan J, Song M, Zhou M, Hu Y. Antibiotic tigecycline enhances cisplatin activity against human hepatocellular carcinoma through inducing mitochondrial dysfunction and oxidative damage. Biochem Biophys Res Commun. 2017 Jan 29;483(1):17–23.10.1016/j.bbrc.2017.01.021
   PubMed Web of Science ®Google Scholar
• Yahav D, Lador A, Paul M, Leibovici L. Efficacy and safety of tigecycline: a systematic review and meta-analysis. J Antimicrob Chemother. 2011 Sep;66(9):1963–71.10.1093/jac/dkr242
   PubMed Web of Science ®Google Scholar
• Fries D, Martini WZ. Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth. 2010 Aug;105(2):116–21.10.1093/bja/aeq161
   PubMed Web of Science ®Google Scholar